Cencora的股价上升,因为分析家提高了价格目标,公司将股息提高12.67%。 Cencora's stock rises as analysts raise price targets, and the company boosts its dividend by 12.67%.

Cencora是一家药品分销公司,在数名分析家提高价格目标后,其股份上升。 Cencora, a pharmaceutical distribution company, saw its shares rise after several analysts raised their price targets. 该公司宣布季度股息为0.55美元,达到12.67%,股票获得“货币购买”共识评级。 The company declared a $0.55 quarterly dividend, up 12.67%, and the stock has a "Moderate Buy" consensus rating. 包括Versor Investment LP在内的机构投资者正在积极购买股份。 Institutional investors, including Versor Investments LP, are actively buying shares. Cencora的首席执行官最近出售了大量股票,而该公司的市场上限为49.05亿美元,P/E比率为33.08。 Cencora's CEO sold a significant amount of stock recently, while the company's market cap is $49.05 billion with a P/E ratio of 33.08.